Rein Therapeutics Inc. (RNTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rein Therapeutics Inc.

    NASDAQ: RNTX · Real-Time Price · USD
    1.19
    0.03 (2.59%)
    At close: Oct 03, 2025, 3:59 PM
    1.19
    0.00%
    After-hours: Oct 03, 2025, 06:21 PM EDT

    Rein Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 12.87M 17.31M 5.19M 3.6M
    Short-Term Investments
    		 n/a n/a 16.05M 42.33M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 2K 2.19M 24K 24K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 676K 746K 631K 25K
    Total Current Assets
    		 13.66M 18.27M 21.87M 48.18M
    Property-Plant & Equipment
    		 1K 19K 110K 280K
    Goodwill & Intangibles
    		 48.53M 85.53M n/a n/a
    Total Long-Term Assets
    		 48.53M 87.74M 134K 304K
    Total Assets
    		 62.19M 106.01M 22.01M 48.48M
    Account Payables
    		 911K 1.19M 1.72M 1.21M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 122K 206K 181K 60K
    Total Current Liabilities
    		 5.75M 4.38M 3.38M 4.51M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 45.28M 91.41M n/a n/a
    Total Long-Term Liabilities
    		 47.05M 94.74M n/a 69K
    Total Liabilities
    		 7.8M 99.12M 3.38M 4.58M
    Total Debt
    		 n/a 48K 33K 162K
    Book Value
    		 54.39M 6.89M 18.62M 43.9M
    Book Value Per Share
    		 3.03K 1.5K 4.1K 9.89K
    Common Stock
    		 108K 91K 91K 91K
    Retained Earnings
    		 -351.4M -288.52M -272.79M -245.46M
    Comprehensive Income
    		 -18K -63K -48K -13K
    Shareholders Equity
    		 54.39M 6.89M 18.62M 43.9M
    Total Investments
    		 n/a n/a 16.05M 42.33M

    Add to Watchlist